These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Clinically significant hearing loss in renal allograft recipients treated with intravenous erythromycin. Vasquez EM; Maddux MS; Sanchez J; Pollak R Arch Intern Med; 1993 Apr; 153(7):879-82. PubMed ID: 8466379 [TBL] [Abstract][Full Text] [Related]
13. Ototoxic liability of erythromycin and analogues. Brummett RE Otolaryngol Clin North Am; 1993 Oct; 26(5):811-9. PubMed ID: 8233490 [TBL] [Abstract][Full Text] [Related]
14. [Chemical synthesis of erythromycin A cyclic carbonate L-aspartate tablets]. Nerlo H; Czarnecki W; Wiktorowicz M; Rudzki Z Ann Univ Mariae Curie Sklodowska Med; 1980; 35():135-41. PubMed ID: 7349060 [No Abstract] [Full Text] [Related]
15. [Clinical study of erythromycin ethyl-succinate in oral surgery. Apropos of 30 cases]. Feki A Inf Dent; 1982 Feb; 64(5):369-72. PubMed ID: 6978850 [No Abstract] [Full Text] [Related]
16. The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. Richards RD; Davenport K; McCallum RW Am J Gastroenterol; 1993 Feb; 88(2):203-7. PubMed ID: 8424421 [TBL] [Abstract][Full Text] [Related]
17. [Clinical experiments with erythromycin stearate in surgery of the oral cavity]. della Ventura A; della Ventura D Odontostomatol Implantoprotesi; 1982; (3):19-23. PubMed ID: 6984149 [No Abstract] [Full Text] [Related]